Legal, Regulatory Matters and Contingencies (Details) $ / shares in Units, $ in Millions						1 Months Ended		9 Months Ended
	Apr. 30, 2022 USD ($) D	Mar. 14, 2022 D $ / shares	Mar. 02, 2022 USD ($) D	Oct. 15, 2021 USD ($)	May 22, 2019 USD ($)	Aug. 31, 2019 USD ($)	Nov. 30, 2016 item	Mar. 31, 2022
NYSE Notices of Failure to Satisfy a Continued Listing Rule or Standard
Legal, Regulatory Matters and Contingencies
Threshold period of specified consecutive trading days | D	30		30
Threshold of minimum shareholders equity			$ 50.0
Threshold of minimum global market capitalization			50.0
Threshold of minimum global market capitalization for initiation of delisting proceedings			$ 15.0
Global market capitalization	$ 33.1
Absolute market capitalization	$ 27.5
Cure period								18 months
Threshold minimum closing price of common stock | $ / shares		$ 1.00
Cure period relating to closing price of common stock		6 months
Period of specified consecutive trading days | D		30
Minimum | NYSE Notices of Failure to Satisfy a Continued Listing Rule or Standard
Legal, Regulatory Matters and Contingencies
Closing price of common stock | $ / shares		$ 1.00
Genus Life Sciences
Legal, Regulatory Matters and Contingencies
Litigation settlement payable to other party				$ 1.5
Government Pricing
Legal, Regulatory Matters and Contingencies
Damages sought, value					$ 9.4
Government Pricing | KUPI
Legal, Regulatory Matters and Contingencies
Damages sought, value						$ 8.1
Shareholder Litigation
Legal, Regulatory Matters and Contingencies
Number of officers | item							2